← Back to all clusters

Cluster 106

12 diseases · 27 shared-gene connections
12 Diseases
17 Unique genes
0.301 Avg. similarity score
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome Most-connected disease (7 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
GATA4 8 / 12 Atrioventricular septal defect, Chromosome 8p23.1 monosomy, Congenital pulmonary valve atresia, GATA4-related congenital heart disease with or without pancreatic hypoplasia or diabetes and 4 more
DLG4 3 / 12 Very long chain acyl-coa dehydrogenase deficiency, Vulto-van silfhout-de vries syndrome, Yorifuji okuno syndrome
GATA6 3 / 12 Atrioventricular septal defect, Pancreatic hypoplasia-diabetes-congenital heart disease syndrome, Yorifuji okuno syndrome
ACADVL 2 / 12 Very long chain acyl-coa dehydrogenase deficiency, Yorifuji okuno syndrome
CRELD1 2 / 12 Atrioventricular septal defect, Partial atrioventricular canal defect
MEF2C 2 / 12 Atrioventricular septal defect, Brain abnormalities developmental delay facial dysmorphism intellectual disability syndrome
TBX5 2 / 12 Atrioventricular septal defect, holt-oram syndrome
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Physiological factors Reactome 2 / 12 118× 1.23e-4 2.66e-3 ✓ sig.
YAP1- and WWTR1 (TAZ)-stimulated gene expression Reactome 2 / 14 101× 1.70e-4 3.44e-3 ✓ sig.
Fatty acid degradation KEGG 2 / 43 32.9× 1.65e-3 1.98e-2 ✓ sig.
Fatty acid metabolism KEGG 2 / 57 24.8× 2.88e-3 2.99e-2 ✓ sig.
Regulation of gap junction activity Reactome 1 / 3 235× 4.24e-3 3.93e-2 ✓ sig.
Beta oxidation of myristoyl-CoA to lauroyl-CoA Reactome 1 / 3 235× 4.24e-3 3.93e-2 ✓ sig.
Beta oxidation of palmitoyl-CoA to myristoyl-CoA Reactome 1 / 3 235× 4.24e-3 3.93e-2 ✓ sig.
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA Reactome 1 / 5 141× 7.06e-3 5.49e-2
Factors involved in megakaryocyte development and platelet production Reactome 2 / 99 14.3× 8.44e-3 6.18e-2
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids Reactome 1 / 6 118× 8.46e-3 6.20e-2
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) Reactome 1 / 7 101× 9.87e-3 6.81e-2
RHO GTPases activate CIT Reactome 1 / 8 88.3× 1.13e-2 7.36e-2
WNT mediated activation of DVL Reactome 1 / 9 78.5× 1.27e-2 7.87e-2
Formation of annular gap junctions Reactome 1 / 11 64.2× 1.55e-2 8.86e-2
WNT5:FZD7-mediated leishmania damping Reactome 1 / 12 58.9× 1.69e-2 9.37e-2

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
atrioventricular canal development GO:0036302 3 / 11 300× 1.03e-7 1.24e-5 ✓ sig.
endocardial cushion development GO:0003197 3 / 13 254× 1.78e-7 1.96e-5 ✓ sig.
regulation of DNA-templated transcription GO:0006355 9 / 1,454 6.8× 1.40e-6 1.08e-4 ✓ sig.
cardiac muscle cell differentiation GO:0055007 3 / 30 110× 2.50e-6 1.72e-4 ✓ sig.
positive regulation of DNA-templated transcription GO:0045893 7 / 778 9.9× 2.85e-6 1.91e-4 ✓ sig.
positive regulation of cardiac muscle cell proliferation GO:0060045 3 / 32 103× 3.05e-6 2.02e-4 ✓ sig.
heart development GO:0007507 5 / 273 20.1× 3.44e-6 2.23e-4 ✓ sig.
positive regulation of transcription by RNA polymerase II GO:0045944 8 / 1,208 7.3× 4.28e-6 2.65e-4 ✓ sig.
NMDA selective glutamate receptor signaling pathway GO:0098989 2 / 6 366× 1.17e-5 5.87e-4 ✓ sig.
atrioventricular node development GO:0003162 2 / 6 366× 1.17e-5 5.87e-4 ✓ sig.
negative regulation of transcription by RNA polymerase II GO:0000122 7 / 1,002 7.7× 1.51e-5 7.22e-4 ✓ sig.
sinoatrial node development GO:0003163 2 / 8 275× 2.17e-5 9.59e-4 ✓ sig.
positive regulation of neuron projection arborization GO:0150012 2 / 8 275× 2.17e-5 9.59e-4 ✓ sig.
outflow tract morphogenesis GO:0003151 3 / 63 52.3× 2.40e-5 1.03e-3 ✓ sig.
heart looping GO:0001947 3 / 64 51.5× 2.52e-5 1.07e-3 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome Yorifuji okuno syndrome 0.400 2 5.06e-8 3.92e-7 ✓ sig.
Very long chain acyl-coa dehydrogenase deficiency Yorifuji okuno syndrome 0.286 2 3.04e-7 2.06e-6 ✓ sig.
Atrioventricular septal defect Partial atrioventricular canal defect 0.154 2 5.57e-7 3.60e-6 ✓ sig.
Atrioventricular septal defect Pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0.154 2 5.57e-7 3.60e-6 ✓ sig.
Atrioventricular septal defect Yorifuji okuno syndrome 0.133 2 3.34e-6 1.89e-5 ✓ sig.
GATA4-related congenital heart disease with or without pancreatic hypoplasia or diabetes Testicular anomaly with congenital heart disease 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital pulmonary valve atresia GATA4-related congenital heart disease with or without pancreatic hypoplasia or diabetes 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Congenital pulmonary valve atresia Testicular anomaly with congenital heart disease 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Chromosome 8p23.1 monosomy GATA4-related congenital heart disease with or without pancreatic hypoplasia or diabetes 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Chromosome 8p23.1 monosomy Congenital pulmonary valve atresia 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Chromosome 8p23.1 monosomy Testicular anomaly with congenital heart disease 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Chromosome 8p23.1 monosomy Pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Partial atrioventricular canal defect Testicular anomaly with congenital heart disease 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome Testicular anomaly with congenital heart disease 0.333 1 1.30e-4 3.90e-4 ✓ sig.
GATA4-related congenital heart disease with or without pancreatic hypoplasia or diabetes Partial atrioventricular canal defect 0.333 1 1.30e-4 3.90e-4 ✓ sig.
GATA4-related congenital heart disease with or without pancreatic hypoplasia or diabetes Pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Congenital pulmonary valve atresia Partial atrioventricular canal defect 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Congenital pulmonary valve atresia Pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Chromosome 8p23.1 monosomy Partial atrioventricular canal defect 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome Partial atrioventricular canal defect 0.250 1 2.60e-4 6.40e-4 ✓ sig.
Chromosome 8p23.1 monosomy Yorifuji okuno syndrome 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Congenital pulmonary valve atresia Yorifuji okuno syndrome 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Testicular anomaly with congenital heart disease Yorifuji okuno syndrome 0.200 1 2.60e-4 6.40e-4 ✓ sig.
Very long chain acyl-coa dehydrogenase deficiency Vulto-van silfhout-de vries syndrome 0.167 1 5.19e-4 1.04e-3 ✓ sig.
Vulto-van silfhout-de vries syndrome Yorifuji okuno syndrome 0.167 1 5.19e-4 1.04e-3 ✓ sig.
Atrioventricular septal defect holt-oram syndrome 0.077 1 7.79e-4 1.39e-3 ✓ sig.
Atrioventricular septal defect Brain abnormalities developmental delay facial dysmorphism intellectual disability syndrome 0.077 1 7.79e-4 1.39e-3 ✓ sig.